LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 65 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2020. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $194,000 | +16.2% | 41,731 | 0.0% | 0.02% | +4.2% |
| Q3 2021 | $167,000 | +13.6% | 41,731 | +21.9% | 0.02% | +20.0% |
| Q2 2021 | $147,000 | -61.2% | 34,231 | -61.7% | 0.02% | -61.5% |
| Q1 2021 | $379,000 | -37.4% | 89,341 | -42.7% | 0.05% | -40.9% |
| Q4 2020 | $605,000 | +412.7% | 155,845 | +431.2% | 0.09% | +388.9% |
| Q3 2020 | $118,000 | -5.6% | 29,336 | 0.0% | 0.02% | -10.0% |
| Q2 2020 | $125,000 | -77.1% | 29,336 | -77.5% | 0.02% | -80.0% |
| Q1 2020 | $547,000 | +24.6% | 130,158 | +90.8% | 0.10% | +66.7% |
| Q1 2019 | $439,000 | -42.6% | 68,216 | +79.5% | 0.06% | -41.7% |
| Q3 2018 | $765,000 | +174.2% | 38,008 | +296.9% | 0.10% | +164.1% |
| Q2 2018 | $279,000 | – | 9,577 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |